3 | Pharmaceutical PreparationsIBA
01/2022
-
01/2020 |
3 | Biomarkers (Surrogate Marker)IBA
01/2022
-
01/2020 |
3 | RNA (Ribonucleic Acid)IBA
01/2022
-
10/2021 |
3 | Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2020
-
09/2014 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
01/2022
-
01/2020 |
2 | Proteins (Proteins, Gene)FDA Link
01/2022
-
10/2021 |
2 | Albumin-Bound PaclitaxelFDA Link
12/2021
-
01/2020 |
2 | SurvivinIBA
01/2021
-
05/2007 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
11/2020
-
01/2016 |
2 | VaccinesIBA
10/2020
-
12/2007 |
2 | PoisonsIBA
01/2020
-
01/2018 |
2 | Etoposide (VP 16)FDA LinkGeneric
01/2020
-
09/2014 |
2 | Immune Checkpoint InhibitorsIBA
12/2019
-
01/2019 |
2 | LuciferasesIBA
05/2013
-
05/2007 |
2 | AntigensIBA
12/2007
-
11/2007 |
2 | Messenger RNA (mRNA)IBA
11/2007
-
05/2007 |
2 | ElementsIBA
11/2007
-
05/2007 |
1 | taxaneIBA
01/2022 |
1 | signal sequence receptorIBA
01/2022 |
1 | ChromatinIBA
10/2021 |
1 | EnzymesIBA
10/2021 |
1 | TransposasesIBA
10/2021 |
1 | DNA (Deoxyribonucleic Acid)IBA
10/2021 |
1 | Nucleic AcidsIBA
10/2021 |
1 | GoldIBA
10/2021 |
1 | SilverIBA
10/2021 |
1 | Chloroquine (Aralen)FDA LinkGeneric
08/2021 |
1 | Antineoplastic Agents (Antineoplastics)IBA
08/2021 |
1 | dipinacoline glutamateIBA
01/2021 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2021 |
1 | SteroidsIBA
11/2020 |
1 | cremophorIBA
01/2020 |
1 | AlbuminsIBA
01/2020 |
1 | Programmed Cell Death 1 ReceptorIBA
01/2020 |
1 | Ribosomal Proteins (Ribosomal Protein)IBA
01/2020 |
1 | ribosomal protein S11IBA
01/2020 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
08/2019 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
08/2019 |
1 | Tetanus Toxoid (Vaccine, Tetanus)FDA Link
08/2015 |
1 | TensinsIBA
09/2014 |
1 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2014 |
1 | Platelet-Derived Growth FactorIBA
09/2014 |
1 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2014 |
1 | ferric oxide (iron oxide)IBA
06/2012 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
05/2012 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
04/2011 |
1 | Temozolomide (Temodar)FDA LinkGeneric
01/2011 |
1 | Carmustine (FIVB)FDA Link
02/2008 |
1 | PolymersIBA
02/2008 |
1 | Interleukin-12 (IL 12)IBA
02/2008 |
1 | ErbB Receptors (EGF Receptor)IBA
12/2007 |
1 | epidermal growth factor receptor VIIIIBA
12/2007 |
1 | Monophenol Monooxygenase (Tyrosinase)IBA
11/2007 |
1 | DNA Transposable Elements (Element, IS)IBA
05/2007 |
1 | MidkineIBA
05/2007 |
1 | CPG-oligonucleotideIBA
11/2006 |
1 | Cyclin EIBA
09/2006 |
1 | adenovirus receptorIBA
09/2006 |
1 | Cyclin D1IBA
09/2006 |
1 | Biological ProductsIBA
11/2005 |